XML 27 R18.htm IDEA: XBRL DOCUMENT v3.22.2
Fair value measurement (Tables)
6 Months Ended
Jun. 30, 2022
Fair value measurement  
Schedule of assets and liabilities measured at fair value on recurring basis

 

Quoted prices
in active
markets
(Level 1)

 

Significant
other
observable
inputs
(Level 2)

 

Significant
unobservable
inputs
(Level 3)

 

Total

 

Classification in Consolidated
balance sheets

(in thousands)

At December 31, 2021

Assets:

Cash and cash equivalents

$

556,256

$

$

$

556,256

Cash and cash equivalents

Restricted cash

3,097

3,097

Other non-current assets

Total assets

$

559,353

$

$

$

559,353

Liabilities:

Contingent consideration

29,542

29,542

Contingent consideration

Derivative financial instrument

2,805

2,805

Other non-current liabilities

Consideration for post-acquisition services

846

846

Other non-current liabilities

Total liabilities

$

$

$

33,193

$

33,193

At June 30, 2022

Assets:

Cash and cash equivalents

$

500,524

$

$

$

500,524

Cash and cash equivalents

Restricted cash

3,142

3,142

Other non-current assets

Total assets

$

503,666

$

$

$

503,666

Liabilities:

Contingent consideration

29,086

29,086

Current portion of contingent consideration; contingent consideration, net of current portion

Derivative financial instrument

2,171

2,171

Other non-current liabilities

Consideration for post-acquisition services

689

689

Other non-current liabilities

Total liabilities

$

$

$

31,946

$

31,946

Schedule of changes in fair value of contingent consideration

Amount of

contingent

consideration

2022

(in thousands)

Balance at December 31, 2021

$

29,542

Change in fair value (presented within research and development expenses)

2,007

Currency translation effects

(2,463)

Balance at June 30, 2022

$

29,086